First Opioid Lawsuit Targeting Pharmacy Benefit Managers
First lawsuit mentions three largest PBMs; PBMs likely to be increasingly targeted in litigation
Opiate Use Linked to Early Mortality in IBD Patients
Heavy use in Crohn's, heavy or moderate use in ulcerative colitis tied to increased risk of death
Polypharmacy More Likely for Cancer Survivors
More cancer survivors prescribed five or more unique medications, including those with abuse potential
New Drug Combo Ups Survival in HER2/neu Uterine Serous Cancer
Adding intravenous trastuzumab to carboplatin-paclitaxel increased progression-free survival
Triple Therapy Tied to Reduced Rate of COPD Exacerbations
Benefits seen for triple therapy with fluticasone furoate, umeclidinium, and vilanterol
Opioid Packaging Often Lacks Info on Safe Storage, Disposal
Instructions for safe disposal of unused opioid medications often inconsistent, infrequent, or absent
Calcium Channel Blockers May Up Pancreatic Cancer Risk in Women
Increased hazard ratios for pancreatic cancer among postmenopausal users of short-acting CCBs
USPSTF: Exercise Interventions Prevent Falls in Seniors
Second recommendation statement finds evidence lacking for benefit of calcium, vitamin D, or both
Nonoptimized Drug Therapy Costs More Than $500 Billion Annually
After initial Rx use, average cost of individual having treatment failure, new medical problem over $2,000
Adjuvant Pembrolizumab Beneficial in Stage III Melanoma
Pembrolizumab linked to significantly longer recurrence-free survival at 15-month follow-up
